Encyclopedia of Autism Spectrum Disorders

2013 Edition
| Editors: Fred R. Volkmar

Trichotillomania

Reference work entry
DOI: https://doi.org/10.1007/978-1-4419-1698-3_1839

Synonyms

Short Description or Definition

Trichotillomania is characterized by recurrent hairpulling that causes noticeable hair loss and significant distress or impairment. A diagnosis of trichotillomania according to DSM-IV also requires that an individual sometimes experience urges prior to pulling and a sense of pleasure, gratification, or relief after pulling. Individuals who do not report urges prior to and a sense of relief after pulling are generally given a diagnosis of chronic hairpulling. Inability to report sensory phenomenon is common and developmentally appropriate in younger children; thus, there is a strong probability that these diagnostic criteria will be removed from future diagnostic criteria.

Categorization

Impulse Control Disorder

Epidemiology

Trichotillomania has an estimated lifetime prevalence of roughly 0.6%. However, the estimated lifetime prevalence increases to roughly 3% when preceding urges and pleasure/relief afterward are removed...

This is a preview of subscription content, log in to check access.

References and Readings

  1. Bloch, M. H., Landeros-Weisenberger, A., Dombrowski, P., Kelmendi, B., Wegner, R., Nudel, J., et al. (2007). Systematic review: Pharmacological and behavioral treatment for trichotillomania. Biological Psychiatry, 62(8), 839–846.PubMedCrossRefGoogle Scholar
  2. Christenson, G. A., Mackenzie, T. B., Mitchell, J. E., & Callies, A. L. (1991). A placebo-controlled, double-blind crossover study of fluoxetine in trichotillomania. American Journal of Psychiatry, 148(11), 1566–1571.PubMedGoogle Scholar
  3. Dougherty, D. D., Loh, R., Jenike, M. A., & Keuthen, N. J. (2006). Single modality versus dual modality treatment for trichotillomania: Sertraline, behavioral therapy, or both? Journal of Clinical Psychiatry, 67(7), 1086–1092.PubMedCrossRefGoogle Scholar
  4. Grant, J. E., Odlaug, B. L., & Kim, S. W. (2009). N-acetylcysteine, a glutamate modulator, in the treatment of trichotillomania: A double-blind, placebo-controlled study. Archives of General Psychiatry, 66(7), 756–763.PubMedCrossRefGoogle Scholar
  5. Keuthen, N. J., Fraim, C., Deckersbach, T., Dougherty, D. D., Baer, L., & Jenike, M. A. (2001). Longitudinal follow-up of naturalistic treatment outcome in patients with trichotillomania. Journal of Clinical Psychiatry, 62(2), 101–107.PubMedCrossRefGoogle Scholar
  6. Ninan, P. T., Rothbaum, B. O., Marsteller, F. A., Knight, B. T., & Eccard, M. B. (2000). A placebo-controlled trial of cognitive-behavioral therapy and clomipramine in trichotillomania. Journal of Clinical Psychiatry, 61(1), 47–50.PubMedCrossRefGoogle Scholar
  7. Streichenwein, S. M., & Thornby, J. I. (1995). A long-term, double-blind, placebo-controlled crossover trial of the efficacy of fluoxetine for trichotillomania. American Journal of Psychiatry, 152(8), 1192–1196.PubMedGoogle Scholar
  8. Swedo, S. E., Leonard, H. L., Rapoport, J. L., Lenane, M. C., Goldberger, E. L., & Cheslow, D. L. (1989). A double-blind comparison of clomipramine and desipramine in the treatment of trichotillomania (hair pulling). New England Journal of Medicine, 321(8), 497–501.PubMedCrossRefGoogle Scholar
  9. Van Ameringen, M. A., Mancini, C. L., Collins, S., Oakman, J. M., & Farvolden, P. (2006). A 12-Week, Double-Blind Trial of Olanzapine and Placebo in the Treatment of Trichotillomania. Paper presented at the American Psychiatric Association 159th Annual Meeting, Toronto, ON.Google Scholar
  10. van Minnen, A., Hoogduin, K. A., Keijsers, G. P., Hellenbrand, I., & Hendriks, G. J. (2003). Treatment of trichotillomania with behavioral therapy or fluoxetine: A randomized, waiting-list controlled study. Archives of General Psychiatry, 60(5), 517–522.PubMedCrossRefGoogle Scholar
  11. Woods, D. W., Flessner, C. A., Franklin, M. E., Keuthen, N. J., Goodwin, R. D., Stein, D. J., et al. (2006). The Trichotillomania Impact Project (TIP): Exploring phenomenology, functional impairment, and treatment utilization. Journal of Clinical Psychiatry, 67(12), 1877–1888.PubMedCrossRefGoogle Scholar
  12. Woods, D. W., Wetterneck, C. T., & Flessner, C. A. (2006). A controlled evaluation of acceptance and commitment therapy plus habit reversal for trichotillomania. Behaviour Research and Therapy, 44, 639–656.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2013

Authors and Affiliations

  1. 1.Yale OCD Research ClinicNew HavenUSA